| P50 | author | Joan Massagué Solé | Q462775 |
| | Stephen B. Baylin | Q28113000 |
| | Linda T Vahdat | Q40149511 |
| | Sevin Turcan | Q42574772 |
| | Andreas Rimner | Q52313562 |
| | Mary Ellen Moynahan | Q57518016 |
| | Venkatraman E Seshan | Q104745215 |
| | Larry Norton | Q37644083 |
| P2093 | author name string | Fang Fang | |
| | Ronglai Shen | |
| | Adriana Heguy | |
| | Timothy A Chan | |
| | Qianxing Mo | |
| | Agnes Viale | |
| | Nita Ahuja | |
| | Andrew Kaufman | |
| | Luc G T Morris | |
| | Dilip Giri | |
| P2860 | cites work | Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains | Q21092474 |
| | BRCA1 affects global DNA methylation through regulation of DNMT1 | Q24298913 |
| | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| | Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry | Q24536837 |
| | Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma | Q24612429 |
| | CpG island methylator phenotype in colorectal cancer | Q24672170 |
| | Statistical significance for genomewide studies | Q24681264 |
| | DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 |
| | Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 |
| | Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer | Q27824847 |
| | Cancer statistics, 2008 | Q27860585 |
| | Worms gang up on bacteria | Q27860588 |
| | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 |
| | Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | The consensus coding sequences of human breast and colorectal cancers | Q27861035 |
| | The genomic landscapes of human breast and colorectal cancers | Q27861078 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 |
| | DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 |
| | Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 |
| | The epigenomics of cancer | Q28289975 |
| | A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 |
| | Genome remodelling in a basal-like breast cancer metastasis and xenograft | Q28395637 |
| | Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis | Q28472991 |
| | Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. | Q44124289 |
| | The fundamental role of epigenetic events in cancer | Q56421597 |
| | Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis | Q57240066 |
| | Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer | Q59565565 |
| | Gene-expression profiles in hereditary breast cancer | Q74111111 |
| | Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors | Q79175646 |
| | Hypermethylation in histologically distinct classes of breast cancer | Q80787663 |
| | Colon cancer: it's CIN or CIMP | Q82175754 |
| | PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 |
| | Genes that mediate breast cancer metastasis to lung | Q29547479 |
| | GenePattern 2.0 | Q29614171 |
| | CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 |
| | Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions | Q29614512 |
| | Gene silencing in cancer in association with promoter hypermethylation | Q29617274 |
| | Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 |
| | Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 |
| | A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 |
| | Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients | Q33540332 |
| | Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. | Q33649722 |
| | LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer | Q33848195 |
| | Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 |
| | Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer | Q34018681 |
| | Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. | Q34477787 |
| | Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors | Q34573834 |
| | DNA methylation markers and early recurrence in stage I lung cancer | Q34761286 |
| | Basal-like breast cancer displays distinct patterns of promoter methylation | Q34982503 |
| | DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations | Q35009790 |
| | Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer | Q35605804 |
| | Lung metastasis genes couple breast tumor size and metastatic spread. | Q35800363 |
| | Molecular concepts analysis links tumors, pathways, mechanisms, and drugs | Q35812701 |
| | High-throughput methylation profiling by MCA coupled to CpG island microarray | Q36004673 |
| | Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer | Q36059237 |
| | DNA methylation profiles of female steroid hormone-driven human malignancies. | Q36566168 |
| | Genetic determinants of cancer metastasis | Q36794312 |
| | The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer | Q37131378 |
| | Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation | Q37133978 |
| | Agglomerative epigenetic aberrations are a common event in human breast cancer | Q37187180 |
| | DNA methylation as a biomarker in breast cancer | Q37620392 |
| | PIK3CA mutation associates with improved outcome in breast cancer. | Q38420422 |
| | Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 |
| | Smad signaling is required to maintain epigenetic silencing during breast cancer progression. | Q39750283 |
| | DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients | Q40060957 |
| | Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells | Q40088678 |
| P433 | issue | 75 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 75ra25 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Breast cancer methylomes establish an epigenomic foundation for metastasis | |
| P478 | volume | 3 | |